Taiwan Pharmaceutical Market Outlook 2013...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 9
2 Taiwan Pharmaceutical Market Outlook 2013 – Introduction 11
2.1 Taiwan Pharmaceutical Market 11
3 Taiwan Pharmaceutical Market Outlook 2013 – Investment Environment 12
3.1 Government and Political Environment 12
3.2 Taiwan Economic Outlook 12
3.3 Foreign Trade and Investment 14
3.4 Investment Incentives – Government Boosting the Biotech Sector 16
3.4.1 Act for the Development of Biotech and New Pharmaceuticals Industry (2007) 16
3.4.2 Diamond Action Plan for Biotechnology Takeoff (2009) 16
3.5 International Appraisal and Membership 17
3.5.1 Patent Prosecution Highway Pilot program 17
3.5.2 Pharmaceutical Inspection Convention and Inspection Cooperation Scheme 17
4 Taiwan Pharmaceutical Market Outlook 2013 – Healthcare System 18
4.1 Healthcare System 18
4.1.1 Department of Health 18
4.1.2 Bureau of National Health Insurance 19
4.1.3 Health Insurance Coverage 20
4.1.4 Health Insurance System Challenges 22
4.1.5 Health Policy Initiatives 23
4.2 Healthcare Expenditure 24
4.2.1 Healthcare Spending 24
4.2.2 Healthcare Expenditure by Type of Service 27
4.2.3 Healthcare Expenditure on Pharmaceutical Products 28
4.2.4 Public Health Expenditure 30
4.3 Healthcare Infrastructure 32
4.3.1 Healthcare Facilities 32
4.3.2 Healthcare Coverage 33
4.3.3 Healthcare Personnel 35
4.4 Population Health 39
4.4.1 Demographics 39
4.4.2 Life Expectancy 41
4.4.3 Mortality 43
5 Taiwan Pharmaceutical Market Outlook 2013 – Regulatory Landscape 45
5.1 Drug Pricing and Reimbursement 45
5.1.1 Drug Reimbursement 45
5.1.2 Pricing Policies 45
5.1.3 Pricing Trends 47
5.1.4 Challenges in the Reimbursement Process 48
5.1.5 Drug Expenditure Target 49
5.2 Policy and Regulatory Environment in Taiwan 49
5.2.1 New Drug Approval 49
5.2.2 Intellectual Property Rights 50
6 Taiwan Pharmaceutical Market Outlook 2013 – Market Overview 52
6.1 Pharmaceutical Market Overview 52
6.2 Pharmaceutical Market Size 53
6.3 Market Segments 54
6.4 Key Therapeutic Areas 58
6.4.1 Respiratory Diseases 61
6.4.2 Digestive Diseases 64
6.4.3 Genitourinary Diseases 67
6.4.4 Circulatory Diseases 69
6.4.5 Malignant Neoplasms 72
6.5 Emerging Areas 77
6.5.1 Orphan Drugs 77
6.6 Drug Distribution and Pharmaceutical Supply Chain 78
6.7 Spending in Pharmaceutical R&D 79
7 Taiwan Pharmaceutical Market Outlook 2013 – Competitive Landscape 80
7.1 Key Foreign Entities 80
7.1.1 Pfizer 80
7.1.2 Sanofi 85
7.1.3 Novartis 89
7.1.4 GlaxoSmithKline 94
7.2 Key Domestic Players 100
7.2.1 The China Chemical & Pharmaceutical Company 100
7.2.2 Standard Chemicals & Pharmaceuticals Co. Ltd. 103
7.2.3 Yung Shin Pharmaceutical. Ind. Co. Ltd. 106
7.2.4 ScinoPharm Taiwan 109
7.2.5 TTY Biopharm Company Limited 114
8 Taiwan Pharmaceutical Market Outlook 2013 – Market Dynamics 117
8.1 Industry Drivers and Opportunities 117
8.2 Barriers to Entry 117
8.3 Recent Industry Activity and Consolidation 118
9 Taiwan Pharmaceutical Market Outlook 2013 – the Way Forward 119
9.1 Key Insights 119
9.2 Market Opportunities 119
9.3 Future Market Outlook 120
10 Taiwan Pharmaceutical Market Outlook 2013 – Appendix 121
10.1 Market Definitions 121
10.2 Abbreviations 121
10.3 Bibliography 123
10.4 Research Methodology 126
10.4.1 Coverage 127
10.4.2 Secondary Research 127
10.4.3 Primary Research 127
10.4.4 Expert Panel Validation 128
10.5 Contact Us 128
10.6 Disclaimer 128